JUVE Awards 2023: Taylor Wessing named "Law Firm of the Year for IP”
27 October 2023
Julius is member of the Practice Area Patents Technology & Life Sciences. He advises national and international clients and represents them in disputes in and out of court. He primarily advises clients from the life sciences sector.
Expertise
Services and Groups
Advising on life sciences regulation
Sectors
Cosmetics, food nutrition & supplements
Real estate & construction
Click here to find out more
Doing Business and Investing in Germany: A guide to help foreign investors
20 September 2022
Briefing
by multiple authors
CV
Since 2020
Salary Partner, Taylor Wessing
2016 – 2019
Senior Associate, Taylor Wessing
2012 – 2014
Research Associate, department for civil law, IP law and competition law (chair of Professor Ohly), Ludwig-Maximilians-Universität, Munich
2016
Admitted as a lawyer, Munich
2014
Second state examination, Munich
2012
First state examination, Munich
Career
Since 2020
Salary Partner, Taylor Wessing
2016 – 2019
Senior Associate, Taylor Wessing
2012 – 2014
Research Associate, department for civil law, IP law and competition law (chair of Professor Ohly), Ludwig-Maximilians-Universität, Munich
Education
2016
Admitted as a lawyer, Munich
2014
Second state examination, Munich
2012
First state examination, Munich
Additional languages
English
Italian
Awards
JUVE Awards 2023
Featured
Law firm of the year for IP Law
Julius's news & insights
Patents & innovation
Click here to find out more
Commission proposal on a Union compulsory license
5 June 2023
Briefing
Related news & insights
Life sciences & healthcare
Click here to find out more
Electronic instructions for use for medical devices
16 September 2024
Briefing
UPC
Click here to find out more
Jurisdiction and Competence in the UPC Clarified: Decision of the UPC Court of Appeal in Aylo vs. Dish and Sling
13 September 2024
Quick read
by Faziel Abdul
Life sciences & healthcare
Click here to find out more
Taylor Wessing advises Cumulus Oncology on its exclusive GPR68 licence and development collaboration with leadXpro
2 September 2024
by multiple authors
Life sciences & healthcare
Click here to find out more
Biopharma partnering monthly update: July 2024
29 August 2024
Quick read
by Alice Matthews and Adrian Toutoungi
Life sciences & healthcare
Click here to find out more
Clinical trials in the medical devices area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #8
22 August 2024
In-depth analysis
Competition, EU & trade
Click here to find out more
CMA: ‘Exiting firm’ defence and speed of the CMA decision
19 August 2024
In-depth analysis
Competition, EU & trade
Click here to find out more
CMA clears Eurofins' acquisition of Cellmark in a record timeframe
19 August 2024
by multiple authors
Patents & innovation
Click here to find out more
FRAND litigation at the UPC: Disclosure of SEP licences – what do we know so far?
13 August 2024
In-depth analysis
by multiple authors
Venture capital
Click here to find out more
Changes to merger control rules in the UK and the EU which are relevant to venture capital firms, private equity and investment funds
9 August 2024
Briefing
Life sciences & healthcare
Click here to find out more
Medical device manufacturers: control your supply chain for MDR and IVDR requirements
1 August 2024
Briefing
by Alison Dennis and Paolo Palmigiano
Related people
Germany